Role of nitric oxide in adenosine receptor-mediated relaxation of porcine coronary artery

Worku Abebe, T. Hussain, H. Olanrewaju, S. J. Mustafa

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

In the present study, using porcine coronary artery rings in vitro, we examined the role of the nitric oxide (NO) pathway in endothelium-dependent vasorelaxant effects of the 5'-uronamide adenosine agonists, 5'-(N- ethylcarboxamido)adenosine (NECA) and 2-[p-(2-carboxyethyl)[phenylethyl- amino-5'-N-ethylcarboxamidoadenosine (CGS-21680) as opposed to the endothelium-independent actions of the C2- and N6-substituted analogues, 2- chloroadenosine (CAD) and N6-cyclopentyladenosine (CPA). The NO synthase inhibitor, N(G)-monomethyl-L-arginine (L-NMMA, 30 μM), and the NO-destroying agent, 6-anilino-5,8-quinolinedione (LY-83583, 10 μM), attenuated the relaxations of endothelium-intact but not -denuded rings to NECA and CGS- 21680. The effect of L-NMMA on NECA-induced relaxation was reversed by L- arginine (100 μM), a substrate for NO synthesis. In the endothelium-intact tissues, both NECA and CGS-21680 elicited enhanced production of nitrite, a stable metabolite of NO. This was also attenuated by L-NMMA or endothelium removal. Furthermore, NECA (10 μM) induced augmentation of guanosine 3',5'- cyclic monophosphate (cGMP) production in the intact arteries, which was also inhibited by L-NMMA, LY-83583, or endothelium removal. In contrast, vasorelaxant responses generated by CAD and CPA were not altered by either L- NMMA or LY-83583. Both agents (10 μM) were also unable to alter nitrite and/or guanosine 3',5'-cyclic monophosphate (cGMP) levels of the coronary artery. The data suggest that endothelium-dependent relaxations of porcine coronary artery evoked by the 5'-uronamide adenosine agonists, NECA and CGS- 21680, involve the release of NO from the endothelium, and cGMP appears to be a mediator for this effect.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume269
Issue number5 38-5
StatePublished - Jan 1 1995
Externally publishedYes

Fingerprint

Purinergic P1 Receptors
Adenosine
Endothelium
Coronary Vessels
Nitric Oxide
omega-N-Methylarginine
Swine
6-anilino-5,8-quinolinedione
Cyclic GMP
Nitrites
Vasodilator Agents
Arginine
2-Chloroadenosine
Adenosine-5'-(N-ethylcarboxamide)
Nitric Oxide Synthase
Arteries
2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine

Keywords

  • 2- chloroadenosine
  • 2-[p(2- carboxyethyl)]phenylethyl-amino-5'-N-ethylcarboxamidoadenosine
  • 5'(N-ethylcarboxamido)adenosine
  • 6-anilino-5,8-quinolinedione
  • N(G)-monomethyl-L- arginine
  • N-cyclopentyladenosine
  • endothelium
  • vascular smooth muscle

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Role of nitric oxide in adenosine receptor-mediated relaxation of porcine coronary artery. / Abebe, Worku; Hussain, T.; Olanrewaju, H.; Mustafa, S. J.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 269, No. 5 38-5, 01.01.1995.

Research output: Contribution to journalArticle

@article{c72447931645431bad19175e0bef9459,
title = "Role of nitric oxide in adenosine receptor-mediated relaxation of porcine coronary artery",
abstract = "In the present study, using porcine coronary artery rings in vitro, we examined the role of the nitric oxide (NO) pathway in endothelium-dependent vasorelaxant effects of the 5'-uronamide adenosine agonists, 5'-(N- ethylcarboxamido)adenosine (NECA) and 2-[p-(2-carboxyethyl)[phenylethyl- amino-5'-N-ethylcarboxamidoadenosine (CGS-21680) as opposed to the endothelium-independent actions of the C2- and N6-substituted analogues, 2- chloroadenosine (CAD) and N6-cyclopentyladenosine (CPA). The NO synthase inhibitor, N(G)-monomethyl-L-arginine (L-NMMA, 30 μM), and the NO-destroying agent, 6-anilino-5,8-quinolinedione (LY-83583, 10 μM), attenuated the relaxations of endothelium-intact but not -denuded rings to NECA and CGS- 21680. The effect of L-NMMA on NECA-induced relaxation was reversed by L- arginine (100 μM), a substrate for NO synthesis. In the endothelium-intact tissues, both NECA and CGS-21680 elicited enhanced production of nitrite, a stable metabolite of NO. This was also attenuated by L-NMMA or endothelium removal. Furthermore, NECA (10 μM) induced augmentation of guanosine 3',5'- cyclic monophosphate (cGMP) production in the intact arteries, which was also inhibited by L-NMMA, LY-83583, or endothelium removal. In contrast, vasorelaxant responses generated by CAD and CPA were not altered by either L- NMMA or LY-83583. Both agents (10 μM) were also unable to alter nitrite and/or guanosine 3',5'-cyclic monophosphate (cGMP) levels of the coronary artery. The data suggest that endothelium-dependent relaxations of porcine coronary artery evoked by the 5'-uronamide adenosine agonists, NECA and CGS- 21680, involve the release of NO from the endothelium, and cGMP appears to be a mediator for this effect.",
keywords = "2- chloroadenosine, 2-[p(2- carboxyethyl)]phenylethyl-amino-5'-N-ethylcarboxamidoadenosine, 5'(N-ethylcarboxamido)adenosine, 6-anilino-5,8-quinolinedione, N(G)-monomethyl-L- arginine, N-cyclopentyladenosine, endothelium, vascular smooth muscle",
author = "Worku Abebe and T. Hussain and H. Olanrewaju and Mustafa, {S. J.}",
year = "1995",
month = "1",
day = "1",
language = "English (US)",
volume = "269",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "5 38-5",

}

TY - JOUR

T1 - Role of nitric oxide in adenosine receptor-mediated relaxation of porcine coronary artery

AU - Abebe, Worku

AU - Hussain, T.

AU - Olanrewaju, H.

AU - Mustafa, S. J.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - In the present study, using porcine coronary artery rings in vitro, we examined the role of the nitric oxide (NO) pathway in endothelium-dependent vasorelaxant effects of the 5'-uronamide adenosine agonists, 5'-(N- ethylcarboxamido)adenosine (NECA) and 2-[p-(2-carboxyethyl)[phenylethyl- amino-5'-N-ethylcarboxamidoadenosine (CGS-21680) as opposed to the endothelium-independent actions of the C2- and N6-substituted analogues, 2- chloroadenosine (CAD) and N6-cyclopentyladenosine (CPA). The NO synthase inhibitor, N(G)-monomethyl-L-arginine (L-NMMA, 30 μM), and the NO-destroying agent, 6-anilino-5,8-quinolinedione (LY-83583, 10 μM), attenuated the relaxations of endothelium-intact but not -denuded rings to NECA and CGS- 21680. The effect of L-NMMA on NECA-induced relaxation was reversed by L- arginine (100 μM), a substrate for NO synthesis. In the endothelium-intact tissues, both NECA and CGS-21680 elicited enhanced production of nitrite, a stable metabolite of NO. This was also attenuated by L-NMMA or endothelium removal. Furthermore, NECA (10 μM) induced augmentation of guanosine 3',5'- cyclic monophosphate (cGMP) production in the intact arteries, which was also inhibited by L-NMMA, LY-83583, or endothelium removal. In contrast, vasorelaxant responses generated by CAD and CPA were not altered by either L- NMMA or LY-83583. Both agents (10 μM) were also unable to alter nitrite and/or guanosine 3',5'-cyclic monophosphate (cGMP) levels of the coronary artery. The data suggest that endothelium-dependent relaxations of porcine coronary artery evoked by the 5'-uronamide adenosine agonists, NECA and CGS- 21680, involve the release of NO from the endothelium, and cGMP appears to be a mediator for this effect.

AB - In the present study, using porcine coronary artery rings in vitro, we examined the role of the nitric oxide (NO) pathway in endothelium-dependent vasorelaxant effects of the 5'-uronamide adenosine agonists, 5'-(N- ethylcarboxamido)adenosine (NECA) and 2-[p-(2-carboxyethyl)[phenylethyl- amino-5'-N-ethylcarboxamidoadenosine (CGS-21680) as opposed to the endothelium-independent actions of the C2- and N6-substituted analogues, 2- chloroadenosine (CAD) and N6-cyclopentyladenosine (CPA). The NO synthase inhibitor, N(G)-monomethyl-L-arginine (L-NMMA, 30 μM), and the NO-destroying agent, 6-anilino-5,8-quinolinedione (LY-83583, 10 μM), attenuated the relaxations of endothelium-intact but not -denuded rings to NECA and CGS- 21680. The effect of L-NMMA on NECA-induced relaxation was reversed by L- arginine (100 μM), a substrate for NO synthesis. In the endothelium-intact tissues, both NECA and CGS-21680 elicited enhanced production of nitrite, a stable metabolite of NO. This was also attenuated by L-NMMA or endothelium removal. Furthermore, NECA (10 μM) induced augmentation of guanosine 3',5'- cyclic monophosphate (cGMP) production in the intact arteries, which was also inhibited by L-NMMA, LY-83583, or endothelium removal. In contrast, vasorelaxant responses generated by CAD and CPA were not altered by either L- NMMA or LY-83583. Both agents (10 μM) were also unable to alter nitrite and/or guanosine 3',5'-cyclic monophosphate (cGMP) levels of the coronary artery. The data suggest that endothelium-dependent relaxations of porcine coronary artery evoked by the 5'-uronamide adenosine agonists, NECA and CGS- 21680, involve the release of NO from the endothelium, and cGMP appears to be a mediator for this effect.

KW - 2- chloroadenosine

KW - 2-[p(2- carboxyethyl)]phenylethyl-amino-5'-N-ethylcarboxamidoadenosine

KW - 5'(N-ethylcarboxamido)adenosine

KW - 6-anilino-5,8-quinolinedione

KW - N(G)-monomethyl-L- arginine

KW - N-cyclopentyladenosine

KW - endothelium

KW - vascular smooth muscle

UR - http://www.scopus.com/inward/record.url?scp=0028892557&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028892557&partnerID=8YFLogxK

M3 - Article

VL - 269

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 5 38-5

ER -